AUB ScholarWorks

The Lebanese Society for Infectious Diseases and Clinical Microbiology (LSIDCM) guidelines for adult Community-Acquired Pneumonia (CAP) in Lebanon

Show simple item record Moghnieh R. Yared Sakr N. Kanj S.S. Musharrafieh U. Husni R. Jradeh M. Al-Awar G. Matar M. Jureij W. Saad A. Azar E. Abi Hanna P. Minari A. Hammoud J. Kfoury J. Mahfouz T. Abou Chakra D. Zaatari M. Tabbarah Z.A.
dc.contributor.editor Jan-2014 2017-10-05T15:42:20Z 2017-10-05T15:42:20Z 2014
dc.identifier 10.12816/0002626
dc.identifier.issn 00239852
dc.description.abstract Adult community-acquired pneumonia (CAP) is a common cause of morbidity and mortality which is managed by different disciplines in a heterogeneous fashion. Development of consensus guidelines to standardize these wide variations in care has become a prime objective. The Lebanese Society of Infectious Diseases and Clinical Microbiology (LSIDCM) convened to set Lebanese national guidelines for the management of CAP since it is a major and a prevalent disease affecting the Lebanese population. These guidelines, besides being helpful in direct clinical practice, play a major role in establishing stewardship programs in hospitals in an effort to contain antimicrobial resistance on the national level. These guidelines are intended for primary care practitioners and emergency medicine phy-sicians. They constitute an appropriate starting point for specialists' consultation being based on the available local epidemiological and resistance data. This document includes the following: 1- Rationale and scope of the guidelines; 2- Microbiology of CAP based on Lebanese data; 3- Clinical presentation and diagnostic workup of CAP; 4- Management and prevention strategies based on the IDSA-ATS Consensus Guidelines, 2007, and the ESCMID Guidelines, 2011, and tailored to the microbiological data in Lebanon; 5- Comparison to regional guidelines. The recommendations made in this document were graded based on the strength of the evidence as in the 2007 IDSA-ATS Consensus Guidelines. Hopefully, these guidelines will be an important step towards standardization of CAP care in Lebanon and set the agenda for further research in this area.
dc.format.extent Pages: (40-47)
dc.language English
dc.publisher Lebanese Order of Physicians;
dc.relation.ispartof Publication Name: Journal Medical Libanais; Publication Year: 2014; Volume: 62; no. 1; Pages: (40-47);
dc.source Scopus
dc.title The Lebanese Society for Infectious Diseases and Clinical Microbiology (LSIDCM) guidelines for adult Community-Acquired Pneumonia (CAP) in Lebanon
dc.type Review
dc.contributor.affiliation Moghnieh, R., Ain Wazein Hospital, Al-Shouf, Lebanon
dc.contributor.affiliation Yared Sakr, N., Mount Lebanon Hospital, Hazmieh, Lebanon
dc.contributor.affiliation Kanj, S.S., Department of Infectious Diseases, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Musharrafieh, U., Department of Infectious Diseases, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Husni, R., Lebanese American University Medical Center Rizk Hospital, Beirut, Lebanon
dc.contributor.affiliation Jradeh, M., Mount Lebanon Hospital, Hazmieh, Lebanon
dc.contributor.affiliation Al-Awar, G., Department of Infectious Diseases, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Matar, M., Notre-Dame de Secours University Hospital, Holy Spirit University of Kaslik, Jbeil, Lebanon
dc.contributor.affiliation Jureij, W., Centre Hospitalier du Nord, Zghorta, Lebanon
dc.contributor.affiliation Saad, A., University of Balamand, Saint George Hospital MUC, Ashrafieh, Lebanon
dc.contributor.affiliation Azar, E., University of Balamand, Saint George Hospital MUC, Ashrafieh, Lebanon
dc.contributor.affiliation Abi Hanna, P., Rafic Hariri University Hospital, Beirut, Lebanon, Sacré-Cœur Hospital, Beirut, Lebanon
dc.contributor.affiliation Minari, A., Sacré-Cœur Hospital, Beirut, Lebanon
dc.contributor.affiliation Hammoud, J., Al-Monla Hospital, Tripoli, Lebanon
dc.contributor.affiliation Kfoury, J., Hayek Hospital, Beirut, Lebanon
dc.contributor.affiliation Mahfouz, T., Nabatieh Governmental Hospital, Nabatieh, Lebanon
dc.contributor.affiliation Abou Chakra, D., Ain Wazein Hospital, Al-Shouf, Lebanon
dc.contributor.affiliation Zaatari, M., Hammoud Hospital, Saida, Lebanon
dc.contributor.affiliation Tabbarah, Z.A., Department of Infectious Diseases, American University of Beirut, Beirut, Lebanon, Rafic Hariri University Hospital, Beirut, Lebanon
dc.contributor.authorAddress Moghnieh, R.; Ain Wazein Hospital, Al-Shouf, Lebanon; email:
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Infectious Diseases;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Infectious Diseases
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.format.extentCount 8
dc.identifier.coden LMJJA
dc.identifier.pubmedID 24684125
dc.identifier.scopusID 84899488680
dc.relation.ispartOfIssue 1
dc.relation.ispartofPubTitle Journal Medical Libanais
dc.relation.ispartofPubTitleAbbr J. Med. Liban.
dc.relation.ispartOfVolume 62
dc.type.publication Journal
dc.subject.otherAuthKeyword Adult community acquired
dc.subject.otherAuthKeyword Lebanon
dc.subject.otherAuthKeyword LSIDCM
dc.subject.otherChemCAS amikacin, 37517-28-5, 39831-55-5
dc.subject.otherChemCAS amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7
dc.subject.otherChemCAS amoxicillin plus clavulanic acid, 74469-00-4, 79198-29-1
dc.subject.otherChemCAS ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0
dc.subject.otherChemCAS azithromycin, 83905-01-5
dc.subject.otherChemCAS cefepime, 88040-23-7
dc.subject.otherChemCAS cefotaxime, 63527-52-6, 64485-93-4
dc.subject.otherChemCAS cefpodoxime, 82619-04-3
dc.subject.otherChemCAS ceftizoxime, 68401-81-0, 68401-82-1
dc.subject.otherChemCAS ceftriaxone, 73384-59-5, 74578-69-1
dc.subject.otherChemCAS cefuroxime, 55268-75-2, 56238-63-2
dc.subject.otherChemCAS ciprofloxacin, 85721-33-1
dc.subject.otherChemCAS clarithromycin, 81103-11-9
dc.subject.otherChemCAS imipenem, 64221-86-9
dc.subject.otherChemCAS levofloxacin, 100986-85-4, 138199-71-0
dc.subject.otherChemCAS linezolid, 165800-03-3
dc.subject.otherChemCAS meropenem, 96036-03-2
dc.subject.otherChemCAS tazobactam, 93528-38-2
dc.subject.otherChemCAS teicoplanin, 61036-62-2, 61036-64-4
dc.subject.otherChemCAS vancomycin, 1404-90-6, 1404-93-9
dc.subject.otherIndex amikacin
dc.subject.otherIndex amoxicillin
dc.subject.otherIndex amoxicillin plus clavulanic acid
dc.subject.otherIndex ampicillin
dc.subject.otherIndex azithromycin
dc.subject.otherIndex cefepime
dc.subject.otherIndex cefotaxime
dc.subject.otherIndex cefpodoxime
dc.subject.otherIndex ceftizoxime
dc.subject.otherIndex ceftriaxone
dc.subject.otherIndex cefuroxime
dc.subject.otherIndex ciprofloxacin
dc.subject.otherIndex clarithromycin
dc.subject.otherIndex imipenem
dc.subject.otherIndex levofloxacin
dc.subject.otherIndex linezolid
dc.subject.otherIndex meropenem
dc.subject.otherIndex quinoline derived antiinfective agent
dc.subject.otherIndex tazobactam
dc.subject.otherIndex teicoplanin
dc.subject.otherIndex vancomycin
dc.subject.otherIndex antiinfective agent
dc.subject.otherIndex antibiotic resistance
dc.subject.otherIndex antimicrobial therapy
dc.subject.otherIndex clinical practice
dc.subject.otherIndex community acquired pneumonia
dc.subject.otherIndex comparative study
dc.subject.otherIndex diagnostic test
dc.subject.otherIndex drug megadose
dc.subject.otherIndex evidence based practice
dc.subject.otherIndex human
dc.subject.otherIndex laboratory test
dc.subject.otherIndex Lebanon
dc.subject.otherIndex medical society
dc.subject.otherIndex microbiological examination
dc.subject.otherIndex microbiology
dc.subject.otherIndex nonhuman
dc.subject.otherIndex penicillin resistance
dc.subject.otherIndex Pneumonia Severity Index
dc.subject.otherIndex population research
dc.subject.otherIndex practice guideline
dc.subject.otherIndex primary medical care
dc.subject.otherIndex review
dc.subject.otherIndex standardization
dc.subject.otherIndex thorax radiography
dc.subject.otherIndex adult
dc.subject.otherIndex aged
dc.subject.otherIndex bacterial pneumonia
dc.subject.otherIndex communicable disease
dc.subject.otherIndex conference paper
dc.subject.otherIndex consensus development
dc.subject.otherIndex emergency health service
dc.subject.otherIndex evidence based medicine
dc.subject.otherIndex female
dc.subject.otherIndex hospital admission
dc.subject.otherIndex male
dc.subject.otherIndex microbial sensitivity test
dc.subject.otherIndex middle aged
dc.subject.otherIndex multidrug resistance
dc.subject.otherIndex practice guideline
dc.subject.otherIndex primary health care
dc.subject.otherIndex randomized controlled trial (topic)
dc.subject.otherIndex statistics
dc.subject.otherIndex Adult
dc.subject.otherIndex Aged
dc.subject.otherIndex Anti-Bacterial Agents
dc.subject.otherIndex Community-Acquired Infections
dc.subject.otherIndex Drug Resistance, Multiple, Bacterial
dc.subject.otherIndex Emergency Service, Hospital
dc.subject.otherIndex Evidence-Based Medicine
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Lebanon
dc.subject.otherIndex Male
dc.subject.otherIndex Microbial Sensitivity Tests
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Patient Admission
dc.subject.otherIndex Pneumonia, Bacterial
dc.subject.otherIndex Primary Health Care
dc.subject.otherIndex Randomized Controlled Trials as Topic

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


My Account